Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Churg

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Reproducibility of visual estimation of lung adenocarcinoma subtype proportionsJoanne Wright, Andrew Churg, Masanori Kitaichi, et al.
American Journal of Respiratory Cell and Molecular Biology|August 30, 2008
Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposureAndrew Churg, Steven Zhou, Olena Preobrazhenska, et al.
AJR. American Journal of Roentgenology|November 24, 2005
Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findingsCarolina Althoff Souza, Nestor L Müller, Julia Flint, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2021
Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation statusJulia R Naso, Basile Tessier-Cloutier, Janine Senz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2019
Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitisJoanne L Wright, Andrew Churg, Cameron J Hague, et al.
The American Journal of Surgical Pathology|January 7, 2004
Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung diseaseAndrew Churg, Jeffrey Myers, Teresa Suarez, et al.
The American Journal of Surgical Pathology|March 31, 2025
CDKN2A Chromogenic In Situ Hybridization for Separating Benign From Malignant Mesothelial ProliferationsAndrew Churg, Tara Spence, Karina C Martin, et al.
Archives of Pathology & Laboratory Medicine|July 25, 2019
In Reply to "Malignant Mesothelioma and Its Nonasbestos Causes"Richard L Attanoos, Andrew Churg, Francoise Galateau-Salle, et al.
Genes & Cancer|February 14, 2017
Switching off malignant mesothelioma: exploiting the hypoxic microenvironmentNoushin Nabavi, Kevin L Bennewith, Andrew Churg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypesAndrew Churg, Kazuki Nabeshima, Greta Ali, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Reproducibility of visual estimation of lung adenocarcinoma subtype proportionsJoanne Wright, Andrew Churg, Masanori Kitaichi, et al.
American Journal of Respiratory Cell and Molecular Biology|August 30, 2008
Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposureAndrew Churg, Steven Zhou, Olena Preobrazhenska, et al.
AJR. American Journal of Roentgenology|November 24, 2005
Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findingsCarolina Althoff Souza, Nestor L Müller, Julia Flint, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2021
Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation statusJulia R Naso, Basile Tessier-Cloutier, Janine Senz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2019
Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitisJoanne L Wright, Andrew Churg, Cameron J Hague, et al.
The American Journal of Surgical Pathology|January 7, 2004
Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung diseaseAndrew Churg, Jeffrey Myers, Teresa Suarez, et al.
The American Journal of Surgical Pathology|March 31, 2025
CDKN2A Chromogenic In Situ Hybridization for Separating Benign From Malignant Mesothelial ProliferationsAndrew Churg, Tara Spence, Karina C Martin, et al.
Archives of Pathology & Laboratory Medicine|July 25, 2019
In Reply to "Malignant Mesothelioma and Its Nonasbestos Causes"Richard L Attanoos, Andrew Churg, Francoise Galateau-Salle, et al.
Genes & Cancer|February 14, 2017
Switching off malignant mesothelioma: exploiting the hypoxic microenvironmentNoushin Nabavi, Kevin L Bennewith, Andrew Churg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypesAndrew Churg, Kazuki Nabeshima, Greta Ali, et al.
Pageof 22